Glioma-targeted therapeutics: computer-aided drug design prospective
Amongst the several types of brain cancers known to humankind, glioma is one of the most
severe and life-threatening types of cancer, comprising 40% of all primary brain tumors …
severe and life-threatening types of cancer, comprising 40% of all primary brain tumors …
Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis
Cancer cells are known to undergo metabolic adaptation to cater to their enhanced energy
demand. Nicotinamide adenine dinucleotide (NAD) is an essential metabolite regulating …
demand. Nicotinamide adenine dinucleotide (NAD) is an essential metabolite regulating …
Identification of a co‐target for enhancing efficacy of sorafenib in HCC through a quantitative modeling approach
Sorafenib (SFB), a multi‐kinase inhibitor, is the only approved drug for treating
hepatocellular carcinoma (HCC). However, SFB shows low efficacy in many cases. HCC …
hepatocellular carcinoma (HCC). However, SFB shows low efficacy in many cases. HCC …
Nicotinamide adenine dinucleotide+ metabolism biomarkers in malignant gliomas
M Jiménez-García, E Verdugo-Sivianes… - Cancer …, 2016 - search.proquest.com
Gliomas are highly metabolically active tumors. Cancer metabolism is currently of great
interest to researchers. Nicotinamide adenine dinucleotide (NAD) is central in cell …
interest to researchers. Nicotinamide adenine dinucleotide (NAD) is central in cell …
[HTML][HTML] Optimización del ensayo de inhibición de la nicotinamida/nicotinato mononucleótido adenililtransferasa de Leishmania braziliensis
CG Granados-Ramírez… - Revista de la …, 2021 - scielo.org.co
La nicotinamida/nicotinato mononucleótido adenililtransferasa (NMNAT, EC 2.7. 7.1/18)
desempeña una función central en la síntesis del dinucleótido de adenina y nicotinamida …
desempeña una función central en la síntesis del dinucleótido de adenina y nicotinamida …